Methodology

All entries for: Altay Therapeutics

November 19, 2025

Altay Therapeutics

Orphan Drug Designation

FDA orphan drug designation: treatment of facioscapulohumeral muscular dystrophy

Disease Area: Rare Diseases
Source
Scroll to Top